Results 91 to 100 of about 1,440 (183)

Adult TWIST2‐high B‐ALL confirms metabolic association but reveals molecular heterogeneity

HemaSphere, Volume 10, Issue 6, June 2026.
Wencke Walter, Veronika Ecker, Wolfgang Kern, Anna Stengel   +3 more
wiley   +1 more source

Covalent Organic Frameworks for Photocatalysis

Advanced Materials, Volume 37, Issue 52, December 29, 2025.
This review provides an overview of recent advances in covalent organic frameworks (COFs) for photocatalysis, focusing on sustainable energy applications like water splitting, hydrogen peroxide generation, and CO2 and N2 reduction. It discusses design principles, structure‐function relationships, challenges in COF photocatalysis, and strategies to ...
Bikash Mishra, Akhtar Alam, Avanti Chakraborty, Bidhan Kumbhakar, Samrat Ghosh, Pradip Pachfule, Arne Thomas   +6 more
wiley   +1 more source

Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients

eJHaem
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) predominantly occurs in adults ≥60 years old; 10–20% of cases are pediatric or adolescent/young adult (AYA) patients.
Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S. Stein, Soheil Meshinchi, Craig A. Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I. Mughal, Anna B. Pawlowska   +11 more
doaj   +1 more source

Bruise-like cutaneous lesions as the early presentation of blastic plasmacytoid dendritic cell neoplasm

Dermatologica Sinica, 2014
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very rare and highly aggressive hematopoietic malignancy associated with a poor prognosis. It has been recognized to originate from precursors of plasmacytoid dendritic cells and has recently been
Yi-Hsuan Chou, Ruey-Yi Lin, Meng-Sui Lee, Hsiao-Ping Wu, Che-Pin Lin, Chen-Yi Wu   +5 more
doaj   +1 more source

: TCL1 and BPDCN diagnosis

, 2012
International audienceDiagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN) or plasmacytoid dendritic cell leukemia (pDCL) is mainly based on immunophenotypical characterization of leukemic cells in blood or bone marrow samples.
Harrivel, Veronique, Angelot-Delettre, Fanny, Deconinck, Eric, Saas, Philippe, Seilles, Estelle, Gaugler, Béatrice, Garnache-Ottou, Francine, Biichle, Sabeha, Ferrand, Christophe, Rosenthal-Allieri, Maria Alessandra   +9 more
core   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects

Blood and Lymphatic Cancer: Targets and Therapy, 2017
Amy M Trottier, Sonia Cerquozzi, Carolyn J Owen Division of Hematology and Hematological Malignancies, University of Calgary, Foothills Medical Centre, Calgary, AB, Canada Abstract: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare CD4+ CD56+
Trottier AM, Cerquozzi S, Owen CJ
doaj  

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Harbors Frequent Splicesosome Mutations That Cause Aberrant RNA Splicing Affecting Genes Critical in pDC Differentiation and Function

, 2016
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive malignancy thought to result from transformation of plasmacytoid dendritic cells (pDCs). Clinical outcomes are poor and pathogenesis is unclear. To better understand BPDCN genomics and
Togami, Katsuhiro, Seiler, Michael, Biichle, Sabeha, Sarkizova, Siranush, Garnache-Ottou, Francine, Lane, Andrew A., Madan, Vikas, Angelot-Delettre, Fanny, Ghandi, Mahmoud, Hammerman, Peter S, Li, Jia, Li, Yvonne, Koeffler, H. Phillip, Villani, Alexandra-Chloe, Buonamici, Silvia, Yang, Henry, Abdel-Wahab, Omar, Buczkowski, Kevin, Hacohen, Nir, Taylor, Justin   +19 more
core   +1 more source

A new palliative treatment for blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature

Journal of International Medical Research, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy that derives from plasmacytoid dendritic cells. The cancer is characterized by aggressive development and dismal prognosis, and due to limited prospective study ...
Yunning Yang, Yuanyuan Xu, You Nie, Hongwei Wang, Shan Long, Xiaosong Li   +5 more
doaj   +1 more source

LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis

, 2016
International audienceBlastic plasmacytoid dendritic cell (PDC) neoplasm (BPDCN) is an aggressive hematological malignancy with a poor prognosis that derives from PDCs.
Fanny Angelot-Delettre, Claude Preudhomme, Macintyre, Elisabeth, Baptiste Lamarthée, Francis Bonnefoy, Lagrost, Laurent, David Masson, Bonnefoy, Francis, Roggy, Anne, Philippe, Laure, Angelot-Delettre, Fanny, Saas, Philippe, Cécile Chagué, Christophe Roumier, Biichle, Sabeha, Perruche, Sylvain, Sylvain Perruche, Roumier, Christophe, Laure Philippe, Chague, Cecile, Garnache-Ottou, Francine, Adam Ceroi, Elisabeth Macintyre, Francine Garnache-Ottou, Lamarthee, Baptiste, Philippe Saas, Masson, David, Thierry Gauthier, Laurent Lagrost, Preudhomme, Claude, Anne Roggy, Ceroi, Adam, Sabeha Biichle, Gauthier, Thierry   +33 more
core   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source